Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2019.0287

PERSPECTIVE
Exploring functional Non-coding mutations for understanding regulatory networks and clinical implications for cancer.

W. CS CHO, MD, PhD.
 

Abstract
The validity of Whole-exome sequencing (WES), Whole-genome sequencing (WGS) and RNA-sequencing in the exploration  of primary tumor and circulating cell-free DNA NGS (cfDNA-NGS) for the identification of intratumor heterogeneity (ITH) and cfDNA-NGS-based genetic, genomic and transcriptional heterogeneity represents major hope for overcoming drug resistance, and relapse rates leading to improved overall survival.

(Citation: Gastric & Breast Cancer 2019; 14(1): 94-109)

Back

 
You can have an online full-text access and a PDF of this article:
  • Either purchase this paper for €35 EUR. Please, click here
Please specify DOI of article
  • Or through one year subscription PayPal

Online ISSN : 1109 - 7647
   Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 10 June 2019